介绍了2.2%吡虫啉.阿维菌素微乳剂和悬浮剂2种剂型配方的筛选和确立。试验研制的2.2%吡虫啉.阿维菌素微乳剂和悬浮剂都具有较好的质量和性能稳定性,其各项质量指标均达到相应的剂型质量标准要求。阐明了研制开发2.2%吡虫啉.阿维菌素水基性制剂的目的,简明比较了2种剂型产品在制作与成本上的优点与不足。 The screening and establishment of two formulations of 2.2% imidacloprid and avermectin microemulsions and suspending agents were introduced. The 2.2% imidacloprid tested and developed by our company have good quality and performance stability, and the quality indexes of all the avermectin microemulsions and suspending agents have reached the corresponding quality standards of dosage forms. The purpose of research and development of 2.2% imidacloprid and avermectin water-based formulations was clarified, and the advantages and disadvantages of both formulations in terms of cost and production were compared.